| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aptevo Therapeutics Inc. (APVO) has 10 insiders with recent SEC Form 4 filings, including 23 buys and 17 sells. APVO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 30.0K | $145.8K | - | |
| COO | 17.3K | $84.1K | - | |
| Dir | 13.5K | $65.7K | - | |
| VP | 11.5K | $55.9K | - | |
| VP | 11.5K | $55.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Grant Grady III | Director | Buy | 13,513 | $1.49 | $20,134.37 | +1,351,300% | -75.4% | - | |
| Nov 23, 2021 | Tang Kevin C86 | Exit Filing | Sell | 921,336 | $11.25 | $10,368,236.34 | -24.2% | -67.7% | -82.6% | |
| Nov 22, 2021 | Tang Kevin C86 | 10% Owner | Sell | 838,664 | $7.75 | $6,500,410.92 | -6.2% | -15.1% | -54.8% | |
| Nov 6, 2020 | Tang Kevin C86 | 10% Owner | Buy | 1,436,675 | $17.30 | $24,849,231.19 | +8.2% | - | - | |
| Aug 16, 2019 | Maddux Randy Joe | SVP Operations, CMO | Buy | 25,000 | $0.76 | $19,000.00 | +50.0% | - | - | |
| Aug 12, 2019 | El-Hibri Fuad | Director | Buy | 100,000 | $0.76 | $75,520.00 | +9.8% | - | - | |
| Jul 29, 2019 | El-Hibri Fuad | Board Of Directors | Buy | 55,015 | $0.83 | $45,860.50 | +5.7% | - | - | |
| Jul 23, 2019 | El-Hibri Fuad | Board Of Directors | Buy | 10,000 | $0.90 | $8,996.00 | +1.0% | - | - | |
| Jul 22, 2019 | El-Hibri Fuad | Board Of Directors | Buy | 30,000 | $0.89 | $26,601.00 | +3.2% | - | - | |
| Jul 19, 2019 | El-Hibri Fuad | Board Of Directors | Buy | 26,460 | $0.90 | $23,739.91 | +2.9% | - | - |